Научном већу медицинског факултета универзитета у београду



жүктеу/скачать 0.52 Mb.
бет4/4
Дата12.06.2016
өлшемі0.52 Mb.
#129934
1   2   3   4

Bećarević M, Andrejević S, Miljić P, Bonači-Nikolić B, Majkić-Singh N. Serum lipids and oxidised LDL antibodies in primary antiphospholipid syndrome. Clin Exp Rheumatol 2007; 25: 361-6.


  1. Pengo V, Bison E, Ruffatti A, Iliceto S. Antibodies to oxidised LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Thromb Res 2008; 122:556-9.

  2. Reshetnyak TM, Seredavkina NV, Mach ES, Alexandrova EN, Novikov AA et al. Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome. Terap Ark 2008; 80: 60-7.

  3. Gladd DA, Olech E. Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes. Curr Rheumatol Rep 2009; 11:43-51.

  4. Merill JT. Antiphospholipid antibodies and atherosclerosis. Chapter 14, Handbook of Systemic Autoimmune Diseases, Volume 10, 2009, Pages 169-183, Carvera RM, Reverter JC, Khamashta M (Eds.)

  5. Amini M, Esmaillzadeh A, Shafaeizadeh S, Behrooz J, Zare M. Relationship between major dietary patterns and metabolic syndrome among individuals with impaired glucose tolerance. Nutrition 2010; 10:986-92.

  6. Ames PRJ. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus 2010; 19:711-6.

  7. Medina G, Gutiérrez-Moreno AL, Vera-Lastra O, Saavedra MA, Jara LJ. Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients. Autoimm Rev 2011; 10:214-7.

  8. Iraj B, Heidari-Beni M, Bakhtiari-Broujeni M, et al. Effect of potato consumption as a high glycemic index food on pre-diabetes adult patient. Pak J Med Sci 2013; 29:412-7.

  9. Iraj B, Heidari-Beni M, Bakhtiary-Broujeni M, et al. The effect of walnut consumption on lipid profiles in the first-degree relatives of type two diabetes mellitus patients (T2DM) with prediabetes. Pak J Med Sci 2013; 29:280-4.

  10. Askani G, Heidari-Beni M, Bakhtiary-Broujeni M, et al. Effect of whole bread and white bread consumption on pre-diabetes patient. Pak J Med Sci 2013; 29:275-9.


Bonači-Nikolić B, Andrejević S, Bukilica M, Urošević I, Nikolić M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol. 2006; 26:438-46.


    1. Briasoulis E, Kamposioras K, Tzovaras V, Pafitanis G, Kostoula A, Mavridis A, Pavlidis N. CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature. Lung Canc 2007; 60:302-6.

    2. Mozo L, Gutierrez C, Gomez J. Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies. J Clin Immunol 2008; 28: 285-90.

    3. Himoto T, Nakai S, Kinekawa F, Yoneyama H; Deguchi A et al. Clinical characteristics of patients with hepatitis C virus related chronic liver disease seropositive for anticentromere antibody. Dig Dis Sci 2009; 54: 360-8.

    4. Tampoia M, Mastrandrea V, Cassano N, Vena GA. Anti-NuMA antibodies in psoriatic patient: considerations about clinical relevance and effect of infliximab treatment. Immunopharm Immunotox 2009; 31:127-9.

    5. Aubin G, Beauvillain C, Jeannin P, Renier G, Chevailler A. Immunologie: Bio Q Rev Francoph Lab 2009; 39:73-4.

    6. Himoto T, Murota M, Yoneyama H et al. Clinical characteristic of patients with autoimmune hepatitis seropositive for anticentromere antibody. Hep Res 2010; 40:786-92.

    7. Szalat R, Ghillani-Dalbin P, Jallouli M, Amoura Z, Musset L, Cacoub P, Sène D. Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature. Autoimm Rev 2010; 9:652-6.

    8. Jung JJ, Kim US. A case of oculomotor nerve palsy associated with antimitotic spindle apparatus. Clin Ophtalmol 2011; 5:549-551.

    9. Amdt T. Beta-A4-amyloid-protein. In: Gressner AM, Amdt T (Eds.) Lexikon der Medizinischen Laboratioriumdiagnostik, Springer Berlin Heidelberg 2013, 3-230.

    10. Vermeersh P, Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimm Rev 2013; 12:998-1003.

    11. Bonroy C, Verfallie C, Smith V, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 2013; 51:1771-9.

    12. Soto ME, Hernandez-Bacerril N, Perez-Chiney AC, Hernandez-Rizo A, telich-Tarriba JE, et al. Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: Analytical study in a specialized health institute, 1 year follow-up. Results Immunol 2014; http://dx.doi.org/10.1016/j.rinim.2013.10.003.


Bonači-Nikolić B, Andrejević S, Radlović N, Davidović I, Sofronić Lj et al. Serological and clinical comparison of children and adults wit anti-endomysial antibodies. J Clin Immunol 2007; 27:163-71.


  1. Juranić Z, Radić J, Konić-Ristić A, Jelić S, Mihaljević B et al. Humoral immunoreactivity to gliadin and tissue transglutaminase is present in some patients with multiple myeloma. BMC Immunol 2008; 9: 22.

  2. Olsen, N.J., Prather, H., Li, Q.-Z., Burns, D.K. Autoantibody profiles in two patients with non-autoimmune muscle disease implicate a role for gliadin autoreactivity. Neuromuscular Disorders 2010; 20:188-91.

  3. Nass FR, Kotze LM, Nisihara RM, et al. Autoantibodies in relatives of celiac disease patients: a follow-up of 6-10 years. Arq Gastroenterol 2012; 49:199-203.

  4. Poddar J. Pediatric and adult celiac disease: similarities and differences. Indian J Gastroent 2013; 5:283-288.

  5. Samasca G, Lupan I, Deleanu D, Cristea V, Makovicky P. Immunological approach of the chalanges of XXI century in celiac disease. Int Rev Immunol 2014; 33:3-8.


Andrejević S, Bonači-Nikolić, Šefik-Bukilica M, Petrović R. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies. Lupus 2007; 16 :788–793.


  1. Shoenfeld Y, Twig G, Katz U, Sherer Y. Autoantibody explosion in antiphospholipid syndrome. J Autoimm 2008; 30:74-83.

  2. Lynch RJ, Platt JL. Escaping from rejection. Transplantation 2009; 88:1233-1236.

  3. Platt JL. Autoantibodies in transplantation. Discov Med 2010; 10:125-133.

  4. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G. New autoantigens in the antiphospholipid syndrome. Autoimm Rev 2011; 10:609-16.


Bonaci-Nikolic B. Jeremic I., Andrejevic S., Sefik-Bukilica M., Stojsavljevic N., Drulovic J. Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis. Lupus 2009; 18:78-80.


  1. Moisini I, Davidson A. BAFF: A local and systemic target in autoimmune diseases. Clin Exp Immunol 2009; 158:155-63.

  2. Eggert M, Zettl UK, Neeck G. Autoantibodies in Autoimmune Diseases. Curr Pharm Des 2010; 16: 1634-43.

  3. Parkhomenko TA, Legostaeva GA, Doronin BM, Buneva VN, Nevinsky GA. IgGs containing light chains of the and type and of all subclasses (IgG1-IgG4) from sera of patients with multiple sclerosis hydrolyze DNA. J Mol Recognit 2010; 23:486-94.

  4. Takahashi K. Isolated Antiphospholipid syndrome of the central nervous system with positive lupus anticoagulant: two case reports. J Med Cases 2010; 1:108-10.

  5. Wang Y, Swiecki M, McCartney SA, Colonna M. dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol Rev 2011; 243:74-90.

  6. Etemadifar M, Sarrami AH. Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases. J Res Med Sci 2011; 16:1619-22.

  7. Berkovich R, Subhani D, Steinman L. Autoimmune comorbid conditions in multiple sclerosis. US Neurology 2011; 7:132-8.

  8. Bahri DM, Khiari H, Essouri A, et al. Systemic lupus erythematosus induced by interferon β1 therapy in a patient with multiple sclerosis. Fundam Clin Pharmacol 2012; 26:210-1.

  9. Feng X, Nicholas NP. Yanamandala M, et al. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J Neurol Sci 2012; 313:48–53.

  10. Takahashi K, Tanaka K. Clinical and magnetic resonance imaging features of multiple sclerosis with autoreactive antibodies in Ishikawa Prefecture, Japan. J Neuroimm 2012; 250: 111-4.

  11. Bahri DM, Khiari H, Essoun A, Laadahar L, Zaraa I, Mirabel A, Meddeb N, Sellami S. Systemic lupus erzthematosus induced by interferon β1 therapy in a patient with multiple sclerosis. Fund Clin Pharm 2012; 26:210-1.

  12. Wallbach M, Grone HJ, Kitye B, Muler G, Koziolek MJ. Nephrotic syndrome in a multiple sclerosis patient receiving long term interferon beta therapy. Am J Kidney Dis 2013; 61:786-9.

  13. Pretel M, Marques L, Espana A. Drug-induced lupus erythematosus. Act Derm Sifilograf 2012; http://dx.doi.org/10.1016/j.ad.2012.09.007

  14. Araujo-Fernandes S, Ahijon-Lana M, Isenberg DA. Drug-induced lupus: including anti-tumor necrosis factor and interferon induced. Lupus 2014; doi: 10.1177/0961203314523871.

  15. Capobianco M, Piccoli G, Neve Vigotti F, Scapoli P, Deagostini MC, et al. Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning. Mult Scler 2014; doi: 10.1177/1352458513519839.

  16. Xiao X, Chang C. Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun. 2014; doi: 10.1016/j.jaut.2014.01.005.


Bonaci-Nikolic B, Jeremic I, Nikolic M, Andrejevic S, Lavadinovic L. High procalcitonin in a patient with drug hypersensitivity syndrome. Internal Medicine 2009; 48: 1471-4.


  1. Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, Kolho E, Ruokonen E. The Finnsepsis Study Group1 Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Critical Care 2010; 14:R205.

  2. Ucal-Bakkal S, Kocak-Tufan Z, Bulut C, Boyraz S, Vahaboğlu G. A case of DRESS syndrome mimicking sepsis. Klimik Dergisi 2011; 24: 132-4.

  3. Cahayanour R, Koesnoe S, Sukmana N. Drug rash, eosinophilia and systemic symptoms. J Indon Med Assoc 2011; 61:179-85.

  4. Castellini EVR, Torres OL, Rodrrigues FMP, Elizalde CV. The DRESS syndrome by carbamazepine igestion: report of a pediatric case. Rev Med Electron 2011; 33:771-9.

  5. Milliken D, Roosinovich E, Wilton H, et al. Drug fever and DRESS syndrome. Brit J Hosp Med 2011; 72:224-8.

  6. Cantarín-Extremera V, Castaño-De La Mota C, Álvarez-Coca J et al. Procalcitonin, a high acute phase reactant in antiepileptic hypersensitivity syndrome in pediatric age. Europ J Paed Neurol 2012; 16:200-2.

  7. Loock J, Lamprecht P, Gross WL. Acute inflammatory syndrome with elevated procalcitonin induced by mycophenolate sodium. J Rheumatol 2012;39;658-59.

  8. Powel B, Smith I. The diagnostic role of procalcitonin in quinine-induced disseminated intravascular coagulation. Anaest Int Care 2013; 41:131-2.

  9. Aksu NM, Aksoy DY, Akkas M, Yilmaz H, Akman C, et al. 25-OH-vitamin D and procalcitonin levels after correction of acute hyperglycemia. Med Sci Mon 2013; 19:264-8.

  10. Ingram N. Procalcitonin: Does it have a role in the diagnosis, management and prognosis of patients with sepsis? J Intensive Care Soc 2013; 14:226-30.

  11. Descamps V. Diagnosis of DRESS (drug reaction with eosinophilia and systemic symptoms) in the intensive care unit: Essential but challenging  Shock 2013;40:437-8.


Bonaci-Nikolic B, Andrejevic S, Pavlovic M, Dimcic Z, Ivanovic B, Nikolic M. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge. Clin Rheum 2010; 29:893-904.


  1. Wilczynska M, Khoo JP, McCann GP. Unusual extracardiac manifestations of isolated native tricuspid valve endocarditis. BMJ Case Reports 2010; doi:10.1136/bcr.11.2009.2502

  2. Riding AM, D’Cruz DP. A case of mistaken identity: subacute bacterial endocarditis associated with p-antiuneutrophil cytoplasmic antibody. BMC Case Reports 2010; doi:10.1136/bcr.09.2010.3299.

  3. Janette JC, Falk JR, Gasim AH. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis Curr Opin Nephrol and Hypert 2011; 20: 263-70.

  4. Kallenberg CGM. What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides? Curr Op Rheum 2011; 23:311-6.

  5. Sandri AM, Elewa U, Poterucha JJ, Fervenza FC. Treatment of hepatitis C- mediated glomerular disease. Nephron Clin Pract 2011; 119:121-9.

  6. Ghrairi N, Bouakkez H, Nahdi I, Dahmouni A, Yalaoui S. Antineutrophil cytoplasmic antibodies in pneumology. IBS 2011; 26:137-142.

  7. Hanf W, Serre, JE, Salmon JH, Fabien N, Ginon I, Dijoud F, Trolliet P. Rapidly progressive ANCA positive glomerulonephritis as the presenting feature of infectious endocarditis. La Rev Méd Intern 2011; 32:116-118.

  8. Uh M, McCormic IA, Kelsall JT. Positive cytoplasmic antineutrophil cytoplasmic antigen with PR3 specificity glomerulonephritis in patient with subacute bacterial endocarditis. J Rheumatol 2011; 38:1527-8.

  9. Frances C, Kluger N, Doutre MS. Vasculitis cutaneas y cutaneosistematicas. EMC Derm 2011; 45:1-20.

  10. Robert SC, Forbes SH, Soleimanian S, Hardley JS. Complements do not lie. BMJ Case reports 2011; doi:10.1136/bcr.08.2011.4705

  11. Nickerson A, Marik PE. Life-threatening ANCA-positive vasculitis associated with rickettsial infection. BMJ Case reports 2012; doi:10.1136/bcr.03.2012.5993.

  12. Forbes SH, Robert SC, Martin JE, Rajakariar R. Acute kidney injury with hematuria, a positive ANCA test, and low levels of complement. Am J Kidney Dis 2012; 59:28-31.

  13. Palazzi C, Buskilia D, D’Angelo S, D’Amico E, Olivieri I. Autoantibodies in patients with chronic hepatitis C infection: pitfalls for the diagnosis of rheumatic diseases. Autoimm Rev 2012; 11:659-663.

  14. Casian A, Jayne D. Current modalities in the diagnosis of pulmonary vasculitis. Exp Opin Med Diag 2012; 6:499-516.

  15. Gerth JH, Groh T, Gröne HJ, Waldherr R, Zimmermann B, Sigusch HH. Nephrotic syndrome in a young man. Three biopsies-three diagnoses. Nephrologe 2012; 7:335-8.

  16. Peng H, Chen WF, Wu C, Chen YR, Peng B, Paudel SD, Lou TQ. Culture-negative subacute bacterial endocarditis masquerades as granulomatosis with polyangitis (Wegener s granulomatosis) involving both kidneys and lung. BMC Nephrol 2012; 13:174.

  17. Ardalan MR, Trilini M. Infective endocarditis mimics ANCA associated glomerulonephritis. Casp J Int Med 2012; 3:496-9.

  18. Yao DT, Yang CD, Ding HH, Ying CM. Clinical features of infective endocarditis with positive antineutrophil cytoplasmic antibodies. J Shang Jao Univ Med Sci 2012; 32: 1482-96.

  19. Barakat AF, Hegazy A, Farag RE, Baky AA, Arafa LF, Farouk A. Role of interferon-gamma and immune response biomarkers in predicting IFN-alpha responsiveness and treatment outcome in patients with hepatitis C. Int J Virol 2012; 8:288-298.

  20. Veerappan I, Prabitha EN, Abraham A, Theodore S, Abraham G. Double ANCA-positive vasculitis in a patient with infective endocarditis. Ind J Nephrol 2012; 22:469-72.

  21. Mandhandi R, Kodumuri V, Rohit A et al. A case of palpable purpura and nephropathy: Occam’s razor or Hickam’s dictum. Am Journal of Therapeutics 2013: 20:572-5.

  22. Konstantinov KN, Emil SN, Barrz M, Kellie S, Tyamaloukas AH. Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies. ISRN Nephrol 2013: doi.org/10.5402/2013/324315.

  23. Rousseau-Gasnon M, Riopel J, Desjardins A, Garceau D, Agharazii M, Desmeules S. Gemella sanguinis endocarditis with c-ANCA/anti-PR-3-associated immune complex necrotizing glomerulonephritis with a 'full-house' pattern on immunofluorescence microscopy. Clin Kidney J 2013; 6:300-4.

  24. Lewis JE, Fu SM, Gaskin F. Autoimmunity, end organ damage, and the origin of autoantibodied and autoreactive T cells in systemic lupus erythematosus. Disc Med 2013;81:85-92.

  25. Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, et al. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepatol 2013; 59:457-66.

  26. Debard A, Thibaudin L, Thibaudin D, Monard E, Almartine E, Cathebras P. Spectrum of ANCA-associated disorders according to serological phenotype in routine care: retrospective case series of 209 patients. J Autoimm Dis Rheumatol 2013;1:36-45.

  27. Ying C-M, Yao D-T, Ding H-H, Yang C-D. Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review. PLoS One 2014; DOI: 10.1371/journal.pone.0089777



Krstić M, Alempijević T, Andrejević S, Zlatanović M, Damjanov N, Ivanović B, Jovanović I, Tarabar D, Milosavljević T. Watermelon stomach in a patient with primary Sjögren's syndrome. Vojnosanit Pregl 2010; 67:256-8.


  1. Lopez RM, Quintanilla RB, Hernandez JLGM, et al. Gastric antral vascular ectasia. Endoscopic treatment with argon plasmacoagulation (APC). Rev Haban Cienc Med 2011; 10:302-4.


Drulović J, Andrejević S, Bonači-Nikolić B, Mijajlović V. Hashimoto's encephalopathy: a long-lasting remission induced by intravenous immunoglobulins. Vojnosanit Pregl 2011; 68:452-454.


  1. Payer J, Petrovic T, Lisy L, Langer P. Hashimoto encephalopathy: a rare intricate syndrome. Int J End Metab 2012; 10:506-14.

  2. Sharp M, Javidan M. Immunomodulation in adult epilepsy: the role of IVIG. Can J Neurol Sci 2012; 39:584-91.

  3. Yoneda M. Hashimoto’s encephalopathy and autoantibodies. Brain and Nerve 2013; 65:365-76.

  4. He L, Li M, Long X-H, Li X-P, Peng Y. A case of Hashimoto’s encephalopathy misdiagnosed as viral encephalitis. Am J Case Rep 2013; 14:366-9.

  5. Olmez I, Moses H, Sriram S, Kirshner H, Lagrange AH, Pawate S. Diagnostic and tharapeutic aspects of Hashimoto’s encephalopathy. J Neurol Sci 2013; 331:67-71.

  6. Koszamy A, Majdan M, Suszek D, Wielosz E, Dryglewska M, Relationship between rheumatoid arthritis activity and antithyroid antibodies. Pol Arch Med Wienet 2013; 123:384-400.


Đorđić M, Matić IZ, Filipović-Lješković I, Džodić R, Sašić M, Erić-Nikolić A, Vuletić A, Kolundžija B, Damjanović A, Grozdanić N, Nikolić S, Pralica J, Dobrosavljević D, Rašković S, Andrejević S, Juranić Z. Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo. BMC Complement Altern Med 2012; 12:109.


  1. Rudnicka L, Lukomska M. Alternaria scalp infection in a patient with alopecia areata. Coexistence or causative relationship? J Derm Case Rep 2012; 6:120-4.


Bonači-Nikolić B, Špuran MM, Andrejević SB, Nikolić MM. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sensitive enteropathy: A possible serological trap (Letter) Clin Chim Acta 2012; 413:822-823.


  1. Pavlidis P, Romanidou O, Roggenbruk D, et al. Neal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn’s disease. Clin Develop Immunol 2012; doi:10.1155/2012/640835.

  2. Komorowski L, Teegen B, Probst C, Aulinger-Stocker K, Sina C, Fellerman K, Stocker W. Autoantibodies against exocrine pancreas in Crohn’s disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohn Col 2012; 7:780-790.

  3. Roggenbuck D, Reinhold D, Werner L, et al. Glycoprotein 2 antibodies in Crohn’s disease. Adv Clin Chem 2013; 60:187-208.

  4. Laiskos C, Spyrou V, Roggenbruk D, Athanasiou LV, Orfanidou T, et al. Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: Implications for the pathogenesis of the human disease. Autoimmunity 2013; 46:388-394.

  5. Kuehnel F, Mietsch M, Buettner T, Vervuert I, Ababneh R, Einspanier A. The influence of gluten on clinical and immunological status of common marmosets (Callithrix jacchus). J Med Primatol 2013; 42:300-9.

  6. Werner L, Sturm A, Roggenbrucj D, Yahav L, Zion T, et al. Antibodies afainsy glycoprotein 2 are novel markers of intestinal inflamation in patients with an ileal pouch. Journal of Crohn’s and colitis 2013; 7:e522-32.


Mitrović M, Peruničić M, Sokić-Milutinović A, Andrejević S, Suvajdžić N. Systemic mastocytosis: case report with literature review. Srp Arh Cel Lek 2012; 140:100-103.


  1. Mutreja D, Purohit A, Singh PK, Pati HP. A 60-year-old lady with leonine facies: A rare diagnosis. Ind J Pathol Microbiol 2012; 55:566-8.


Dobrić S, Popović D; Nikolić MM, Andrejević S, Špuran M, Bonači-Nikolić B. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clin Chem Lab Med 2012; 50:503-9.


  1. Korkmaz KS, de Rooij B-JF, van Hoek B, Janse M, Coenraad MJ et al. MMP-2 is a disease-modifying gene in primary sclerosing cholangitis. Liver Int 2014; 34:274-80.

  2. Roggenbuck D, Reinhold D, Schierack P, Bogdanos DP, Conrad K, Laass MW. Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges. Clin Chem Lab Med. 2014; 1;52:483-94.

  3. Alrifai SB, Al-Khazraji KA, Al-Ani MM, Mustafa LK. The role of anti-lactoferin and anti-lysozyme autoantibodied in ulcerative colitis: serological study. IOSR J Appl Chem 2013; 5:2278-36.

  4. Selmi C, Chighizola CB, Ceribelli A, De Santis M, Meroni PL, Zhong R. The geoepidemiology of autoimmune liver disease. Liver Immunol 2014; DOI 10.1007/978-3-319-02096-9_3



Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B. Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA is the most closely associated with the disease activity. Clin Rheumatol 2013; 32: 1619-26.


  1. Borba HHL, Wiens A, de Souza TT, Correr CJ, Pontarolo R. Efficacy and Safety of Biologic Therapies for Systemic Lupus Erythematosus Treatment: Systematic Review and Meta-Analysis. Bio Drugs 2013; DOI: 10.1007/s40259-013-0074-x.


ЗАКЉУЧАК

Др сц Слађана Андрејевић је оригинални научни допринос дала у области аутоимуности истраживањима која доприносе расветљавању улоге аутоантитела у развоју инфламације и обољења.

Научни допринос је везан за налазе који показују да: а) антифосфолипидна антитела имају патогени потенцијал који није везан за њихов афинитет, као и да њихова удруженост са антимитохондријским антителима М5 типа и антителима против ламина доводи до клиничких манифестација АФС-а; б) антинеутрофилна цитоплазматска антитела могу бити индукована лековима, инфекцијама, или настају услед примарног процеса. Њихова антигена специфичност и удруженост са другим антителима опредељује њихову улогу у настанку болести; в) утврђивање присуства криоглобулина и аутоантитела помаже у дијагностиковању инфекција, аутоимунских и лимфопролифе-ративних болести; г) серолошки маркери (активност DNase I, концентрација високо афинитетних анти- dsDNA антитела) утичу на прогнозу и ток системског еритемског лупуса.

Посебно је вреднована активност др Слађане Андрејевић везана за успешно руковођење

пројектним задацима, педагошки рад, као и активности у широј друштвеној заједници (ангажовање у области примарних имунодефицијенција, посебно хередитарног ангиоедема) и широј академској заједници (научна рецензија у међународним часописима и учешће у организацији научних скупова). Такође је вреднована способност др Слађане Андрејевић да оствари сарадњу на реализацији истраживачких задатака и клиничких испитивања са колегама из других иностраних центара.

На основу целокупне истраживачке активности др Слађане Андрејевић везане за област клиничке имунологије, а посебно на основу оних резултата који су објављени у часописима међународног значаја (укупно 30, а од избора у последње научно звање публиковано је 12 радова) и цитирани у радовима других аутора (до сада 248 пута), може се закључити да др Слађана Андрејевић има јасно одређене правце истраживања, способност да постављене истраживачке задатке успешно реализује и искаже на истраживачком пољу којим се бави. Својим истраживањима она доприноси фундаменталним сазнањима у области имунологије, која уједно могу имати примењљив клинички значај.

На основу свих претходно изнетих чињеница чланови Комисије су сагласни да др Слађана Андрејевић испуњава све законом предвиђене услове за реизбор у звање виши научни сарадник, па стога предлажу Научном већу Медицинског факултета Универзитета у Београду да усвоји овај извештај и да се др Слађана Андрејевић реизабере у звање виши научни сарадник.

у Београду, 7. марта 2014.



Чланови Комисије:

Проф. др Вера Правица – председник

ванредни професор Универзитета у Београду - Медицински факултет

Проф. др Јелена Друловић

редовни професор Универзитета у Београду – Медицински факултет

Проф. др Бранка Боначи-Николић

ванредни професор Универзитета у Београду - Медицински факултет

Др сц.Станислава Стошић-Грујичић

научни саветник

Институт за биолошка истраживања „Синиша Станковић“


Др сц. Мирјана Димитријевић

научни саветник

Институт за вирусологију, вакцине и серуме „Торлак“







жүктеу/скачать 0.52 Mb.

Достарыңызбен бөлісу:
1   2   3   4



©dereksiz.org 2024
әкімшілігінің қараңыз
    Басты бет